Risk factors predicting lower extremity amputations in patients with NIDDM

Diabetes Care

Volumn 19, Issue 6, 1996, Pages 607-612

  Lehto, Seppo ^a   Rönnemaa, Tapani ^b,c   Pyörälä, Kalevi ^a   Laakso, Markku ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACHILLES REFLEX; ADULT; ARTICLE; CORONARY RISK; DIABETIC FOOT; FEMALE; FOLLOW UP; FOOT AMPUTATION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 0029954662     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.6.607     Document Type: Article

References (43)

1. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
2. Kannel WB, McGee DL: Diabetes and cardiovascular disease: The Framingham Study. JAMA 241:2035-2038, 1979
3. Herman JB, Medalie JH, Goldbourt U: Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics. Diabetologia 13:229-234, 1977
4. Reunanen A, Takkunen H, Aromaa A: Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 211:249-256, 1982
5. Most RS, Sinnock P: The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6:87-91, 1983
6. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyöralä K: Lower-extremity amputations in diabetic and nondiabetic patients: a population-based study in eastern Finland. Diabetes Care 16:16-20, 1993
7. Nelson RG, Gohdes DM, Everhart JE, Mariner JA, Zwemer FL, Pettitt DJ, Knowler WC: Lower-extremity amputations in NIDDM: 12-yr follow-up study in Pima Indians. Diabetes Care 11:8-16, 1988
8. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA: Lower-extremity amputation in people with diabetes: epidemiology and prevention. Diabetes Care 12:24-31, 1989
9. Kreines K, Johnson E, Albrink M, Knatterud GL, Levin ME, Lewitan A, Nowbery W, Rose FA: The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 8:235-243, 1985
10. Lee JS, Lu M, Lee VS, Russell D, Bahr C, Lee ET: Lower-extremity amputation: incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes 42:876-882, 1993
11. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I: Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and non-diabetic subjects in Finland. Diabetes Care 11:449-463, 1988
12. Madsbad S, Alberti KG, Binder C, Burrin JM, Faber OK, Krarup T, Regeur L: Role of residual insulin secretion in protecting against ketoasidosis in insulin-dependent diabetes. Br Med J 2:1257-1259, 1979
13. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
14. Laakso M, Reunanen A, Klaukka T, Aromaa A, Maatela J, Pyörälä K: Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987. Am J Epidemiol 133:850-857, 1991
15. World Health Organization: Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA Project). Geneva, World Health Org., 1983 (Publication WHO/MNC/82.1, revision 1)
16. Weinfield FD: The national survey of stroke. Stroke 12 (Suppl. 1):I32-I37, 1981
17. Faber OK, Binder C: C-peptide response to glucagon: a test for the residual betacell function in diabetes mellitus. Diabetes 26: 605-610, 1977
18. Kostner GM: Enzymatic determination of cholesterol in high density lipoproiein fractions prepared by polyanion precipitation. Clin Chem 22:695-698, 1976
19. Cox DR: Regression models and life-tables. J R Stat Soc 34:187-201, 1972
20. Garg A, Grundy SM: Management of dyslipidemia in NlDDM. Diabetes Care 13: 153-169, 1990
21. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
22. UK Prospective Study Group: UK Prospective Diabetes Study (UKPG). VIII. Study design, progress and performance. Diabetologia 34:877-890, 1991
23. Winegrad AI, Simmons DA, Martin DB: Has one diabetic complication been explained? N Engl J Med 308:152-154, 1983
24. Harati Y: Diabetic peripheral neuropathies. Ann Intern Med 107:546-559, 1987
25. Beach KW, Strandness DEJ: Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin dependent diabetes. Diabetes 29:882-888, 1980
26. Janka HU, Standl E, Mehnert H: Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasonic technique. Diabetes Care 3:207-213, 1980
27. Flynn MD, Tooke JE: Aetiology of diabetic foot ulceration: a role for the microcirculation? Diabetic Med 9:320-329, 1992
28. Louie TJ, Bartlett JG, Tally FP, Gorbach SL: Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 85:461-463, 1976
29. Lipsky BA, Pecoraro RE, Ahroni JH: Foot ulceration and infections in elderly diabetics. Clin Geriatr Med 6:747-769, 1990
30. Boulton AJM, Kubrusly DB, Bowker JH, Gadia MT, Quintero L, Becker DM, Skyler JS, Sosenko JM: Impaired vibratory perception and diabetic foot ulceration. Diabetic Med 3:335-337, 1986
31. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K: 5-year incidence of the atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation 82:27-36, 1990
32. Kannel WB, McGee DL: Update on some epidemiological features of intermittent claudication: The Framingham Study. J Am Geriatr Soc 33:13-18, 1985
33. Bliss BP, Kirk CJC, Newall RC: Abnormalities in glucose tolerance, lipid and lipoprotein levels in patients with atherosclerotic peripheral arterial disease. Angiology 23:69-75, 1972
34. Cardia G, Grisorio D, Impedovo G, Lillo A, Regina G: Plasma lipids as a risk factor in peripheral vascular disease. Angiology 41:19-22, 1990
35. Beach KW: The correlation of arteriosclerosis obliterans with lipoproteins in insulin dependent and non-insulin dependent diabetes. Diabetes 28:830-840, 1979
36. Fowkes FGR, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, Ruckley CV: Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 135:331-340, 1992
37. Siitonen O, Uusitupa M, Pyörälä K, Voutilainen E, Länsimies E: Peripheral arterial disease and its relationship to cardiovascular risk factors and coronary heart disease in newly diagnosed non-insulin-dependent diabetics. Acta Med Scand 220: 205-212, 1986
38. Bihari-Varga M, Szekely J, Gruber E: Plasma high density lipoproteins in coronary, cerebral and peripheral vascular diseases. The influence of various risk factors. Atherosclerosis 40:337-345, 1981
39. West KM, Ahuja MMS, Bennett PH, Czyzyk A, De-Acosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K: The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 6:361-369, 1983
40. Lord JW: Cigarette smoking and peripheral atherosclerotic occlusive disease. JAMA 191:249-251, 1965
41. Kannel WB, Shurtleff D: The Framingham study, cigarettes and the development of intermittent claudication. Geriatrics 28: 61-68, 1973
42. Fowkes FGR: Aetiology of peripheral atherosclerosis. Br Med J 298:405-406, 1989
43. Welborn TA, Knuiman M, McCann V, Stanton K, Constable IJ: Clinical macrovascular disease in caucasoid diabetic subjects: logistic regression analysis of risk variables. Diabetologia 27:568-575, 1984